Literature DB >> 26399456

MiR-199a/b-3p suppresses migration and invasion of breast cancer cells by downregulating PAK4/MEK/ERK signaling pathway.

Shou-Qing Li1,2, Zi-Hang Wang3, Xu-Guang Mi2, Lei Liu2, Yan Tan1,2.   

Abstract

MicroRNA-199a/b-3p is downregulated in several types of aggressive cancer, and its decrement significantly correlates with poor survival. Here, we aim to investigate the biological function of miR-199a/b-3p and its regulation of target genes in breast cancer cells with highly metastatic potential. In addition, we found that miR-199a/b-3p expression was much lower in MDA-MB-231, CAL120, and HCC1395 breast cancer cells with highly metastatic potential. Functional assays showed that restored miR-199a/b-3p expression inhibited MDA-MB-231 cell growth, cell-cycle progression, migration, and invasion. In addition, we experimentally demonstrated that PAK4 was the direct target of miR-199a/b-3p, hypo-expression of PAK4 suppressed proliferation, migration and invasion of MDA-MB-231 cells, and overexpression of PAK4 significantly rescued the inhibitory effect of miR-199a/b-3p on MDA-MB-231 cell growth, migration, and invasion. Further, we also observed that miR-199a/b-3p could inactivate the PAK4/MEK/ERK signaling pathway. Thus, miR-199a/b-3p functions as a tumor suppressor and has an important role in breast cancer metastasis through PAK4/MEK/ERK signaling pathway.
© 2015 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  PAK4; breast cancer; cancer metastasis; miR-199a/b-3p

Mesh:

Substances:

Year:  2015        PMID: 26399456     DOI: 10.1002/iub.1433

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  22 in total

1.  Group II p21-activated kinase, PAK4, is needed for activation of focal adhesion kinases, MAPK, GSK3, and β-catenin in rat pancreatic acinar cells.

Authors:  Irene Ramos-Álvarez; Lingaku Lee; Robert T Jensen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-27       Impact factor: 4.052

2.  P21-activated kinase 4 in pancreatic acinar cells is activated by numerous gastrointestinal hormones/neurotransmitters and growth factors by novel signaling, and its activation stimulates secretory/growth cascades.

Authors:  Irene Ramos-Alvarez; R T Jensen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-04-19       Impact factor: 4.052

3.  MicroRNA-199a-3p promotes drug sensitivity in triple negative breast cancer by down-regulation of BRCA1.

Authors:  John Chi-Wang Ho; Jiawei Chen; Isabella Wai-Yin Cheuk; Man-Ting Siu; Vivian Yvonne Shin; Ava Kwong
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

4.  Therapeutically actionable PAK4 is amplified, overexpressed, and involved in bladder cancer progression.

Authors:  Darshan S Chandrashekar; Balabhadrapatruni V S K Chakravarthi; Alyncia D Robinson; Joshua C Anderson; Sumit Agarwal; Sai Akshaya Hodigere Balasubramanya; Marie-Lisa Eich; Akhilesh Kumar Bajpai; Sravanthi Davuluri; Maya S Guru; Arjun S Guru; Gurudatta Naik; Deborah L Della Manna; Kshitish K Acharya; Shannon Carskadon; Upender Manne; David K Crossman; James E Ferguson; William E Grizzle; Nallasivam Palanisamy; Christopher D Willey; Michael R Crowley; George J Netto; Eddy S Yang; Sooryanarayana Varambally; Guru Sonpavde
Journal:  Oncogene       Date:  2020-03-30       Impact factor: 9.867

Review 5.  p21-Activated kinases as promising therapeutic targets in hematological malignancies.

Authors:  Andrew Wu; Xiaoyan Jiang
Journal:  Leukemia       Date:  2021-10-25       Impact factor: 11.528

6.  Up-regulated microRNA-199b-3p represses the apoptosis of cerebral microvascular endothelial cells in ischemic stroke through down-regulation of MAPK/ERK/EGR1 axis.

Authors:  Ya-Xiong Yong; Hua Yang; Jia Lian; Xiao-Wei Xu; Ke Han; Ming-Yi Hu; Hua-Cheng Wang; Lie-Min Zhou
Journal:  Cell Cycle       Date:  2019-07-10       Impact factor: 5.173

7.  MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway.

Authors:  Bin Zeng; Wei Shi; Gao Tan
Journal:  BMC Cancer       Date:  2018-01-05       Impact factor: 4.430

8.  Unravelling site-specific breast cancer metastasis: a microRNA expression profiling study.

Authors:  Willemijne A M E Schrijver; Paul J van Diest; Cathy B Moelans
Journal:  Oncotarget       Date:  2017-01-10

9.  A novel orally bioavailable compound KPT-9274 inhibits PAK4, and blocks triple negative breast cancer tumor growth.

Authors:  Chetan Rane; William Senapedis; Erkan Baloglu; Yosef Landesman; Marsha Crochiere; Soumyasri Das-Gupta; Audrey Minden
Journal:  Sci Rep       Date:  2017-02-15       Impact factor: 4.379

10.  Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer.

Authors:  Takashi Sakaguchi; Hirofumi Yoshino; Masaya Yonemori; Kazutaka Miyamoto; Satoshi Sugita; Ryosuke Matsushita; Toshihiko Itesako; Shuichi Tatarano; Masayuki Nakagawa; Hideki Enokida
Journal:  Br J Cancer       Date:  2017-03-21       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.